Bymetric
UK company intelligence
Company Active LTD

Company profile

Aparon Ltd

arden biotechnology

Aparon Ltd is a UK company with status active founded in 2016.

CRN
10473210
Founded
2016
Age
9

Overview

Legal name
APARON LTD
Region
Unknown
Registered address
HILL FARM MIDDLETON LANE
MIDDLETON
TAMWORTH
ENGLAND
B78 2BN
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
15

Company events

Reference milestones and recent Companies House filing stream events.

7 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

23 Nov
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

09 Nov
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

27 Nov
2024

Confirmation Statement With No Updates

Confirmation-statement

CS01 | Transaction MzQ0NTEzODI5OWFkaXF6a2N4

Published 27 Nov 2024 01:58

30 Sep
2024

Accounts With Accounts Type Total Exemption Full

Accounts Analysed

AA | Transaction MzQzNzc3ODc4NWFkaXF6a2N4

Published 30 Sep 2024 03:39

10 Nov
2016

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2019
Funded years
2019, 2020, 2021
Age at first award
2 years

Projects

2021 Collaborative R&D Lead participant

Financial Extension to Project: Novel Biocontrol to Combat Clostridium Perfringens in Poultry Flocks (Phagiotic)

1 Dec 2021 to 31 Jan 2022

Awarded
£57,583
Total cost £82,262

This project is to develop a novel biocontrol ready for commercial sales to combat _Clostridium perfringens_ (CP) in commercial poultry flocks. CP is the bacterium that causes Necrotic Enteritis (NE) in chickens. NE and subclinical NE are estimated to cost the global poultry industry over $6bn pa due to poor feed energy conversion levels, mortalities, vet...

2021 Collaborative R&D Lead participant

Development of bacteriophage cocktail to control Enterococcus cecorum in the poultry sector to increase productivity and sustainability

1 Nov 2021 to 31 Oct 2023

Awarded
£261,469
Total cost £373,527

Through this 24 months industrial research project Arden Biotechnology (global leaders in bacteriophage research) and Avara foods (one of the UK's largest poultry integrators) are developing a novel bacteriophage solution to replace banned antimicrobial growth promoters to prophylactically control the opportunistic avian pathogen _Enterococcus cecorum_ fr...

2020 Feasibility Studies Lead participant

Sustainability and Supply Chain Benefits of Antibiotic Replacement Technology for Canadian and UK Livestock Sectors

1 Nov 2020 to 31 Oct 2022

Awarded
£247,846
Total cost £354,066

Feed usage accounts for ~78% of poultry farming greenhouse-gas-emissions. In response to a growing demand to enhance sustainability in poultry production in the UK, Canada (and worldwide), the consortium (Arden Biotechnology, UK & TrustBIX CA) wishes to address the financially debilitating and poor feed utilising disease in poultry, necrotic enteritis (NE...

2019 Collaborative R&D Lead participant

Novel Biocontrol to Combat Clostridium Perfringens in Poultry Flocks (Phagiotic)

1 Jan 2019 to 30 Sep 2022

Awarded
£566,629
Total cost £809,471

This project is to develop a novel biocontrol ready for commercial sales to combat Clostridium perfringens (CP) in commercial poultry flocks. CP is the bacterium that causes Necrotic Enteritis (NE) in chickens. NE & subclinical NE are estimated to cost global poultry industry over $6bn pa due to poor feed energy conversion levels, mortalities, vet & medic...

Product types

Collaborative R&D Feasibility Studies